Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease

Annals of Thoracic Surgery

Volumn 64, Issue 4, 1997, Pages 1004-1012

  Poston Jr , Robert S ^a   Billingham, Margaret E ^a   Pollard, Jeffrey ^a   Hoyt, E Grant ^a   Robbins, Robert C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HEART MUSCLE REPERFUSION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; CORONARY DISEASE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; HEART TRANSPLANTATION; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, INBRED ACI; RATS, INBRED STRAINS; RNA, MESSENGER; TRANSPLANTATION, HETEROTOPIC; UP-REGULATION;

EID: 0343580456     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00816-3     Document Type: Article

References (29)

1. Narrod J, Kormos R, Armitage J, Hardesty R, Griffith B. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant. 8:1989;418-420.
2. Gao S, Schroeder J, Alderman E, Hunt S, Valantine H, Stinson E. Prevalence of accelerate coronary artery disease in heart transplant survivors comparison of cyclosporine and azathioprine regimens . Circulation. 80:(Suppl 3):1989;100-105.
3. Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and nonspecific, early and late chronic events after organ transplantation. Transplant Rev. 10:1996;108-127.
4. Stein D, Drinkwater D, Laks H, Capouya E, Gates R. Cardiac preservation in patients undergoing transplantation. A clinical trial comparing University of Wisconsin solution and Stanford solution. J Thorac Cardiovasc Surg. 102:1991;657-665.
5. Pearl J, Drinkwater D, Laks H, Capouya E, Gates R. Leukocyte-depleted reperfusion of transplanted human hearts a randomized, double blind clinical trial . J Heart Lung Transplant. 11:1992;1082-1092.
6. Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation. 49:1990;103-107.
7. Troppmann C, Gillinghan K, Benedetti E. Delayed graft function, acute rejection, and outcome after cadaveric renal transplantation. A multivariate analysis. Transplantation. 59:1995;962-968.
8. Palombo JD, Burke PA, Moldawer LL, Forse RA, Lewis WD, Jenkins RL. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation. J Am Coll Surg. 179:1994;209-219.
9. Kukielka GL, Hawkins HK, Michael L. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest. 92:1993;1504-1516.
10. Entman M, Youker K, Shoji T, Kukielka G, Shappell S, Smith C. Neutrophil induced oxidative injury of cardiac myocytes a compartmented system requiring CD11b/CD18-ICAM-1 adherence . J Clin Invest. 90:1992;1335-1345.
11. Poston R, Ing D, Pollard J, Hoyt E, Robbins R. Upregulation of ICAM-1 leads to increased reperfusion injury after global cardiac ischemia. Surgical Forum. 47:1996;233-236.
12. Entman M, Youker K, Shappell S, Seigel C, Smith C. Neutrophil adherence to isolated adult canine myocytes evidence for a CD18-dependent mechanism . J Clin Invest. 85:1990;1497-1506.
13. Poston R, Billingham M, Pollard J, Hoyt E, Morris R, Robbins R. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model [Abstract]. Circulation. 94:(Suppl 1):1996;648.
14. Panes J, Perry M, Anderson D. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol. 269:1995;H1955-H1964.
15. Tamiya Y, Yamamoto N, Uede T. Protective effect of monoclonal antibodies against LFA-1 and ICAM-1 on myocardial reperfusion injury following global ischemia in rat hearts. Immunopharmacology. 29:1995;53-63.
16. Stuart R, Baumgartner W, Borkon A. Five-hour hypothermic lung preservation with oxygen free-radical scavengers. Transplant Proc. 17:1985;1454-1459.
17. Parks D, Bulkley G, Granger D. Role of oxygen free radicalsin shock, ischemia, and organ preservation. Surgery. 94:1983;428-433.
18. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation. 57:1994;211-217.
19. Terasaki P, Cecka J, Gjertson D. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 333:1995;333-336.
20. Knight R, Dickman S, Liu H, Martinelli G. The influence of cold ischemia on the rate of progression to chronic rejection in the rat cardiac allograft model. 15th Annual Meeting of the Society of Transplant Physicians 1996; Abstract #433.
21. Wanders A, Akyurek ML, Waltenberger J, et al. Ischemia-induced transplant arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol. 15:1995;145-155.
22. Tullius SG, Heemann U, Hancock WW, Azuma H, Tilney NL. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994;220:425-32; discussion 432-435.
23. Hancock WH, Whitley WD, Tullius SG, et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation. 56:1993;643-650.
24. Labarrere C, Nelson D, Page-Faulk W. Endothelial activation as a risk factor for coronary artery disease in transplanted human hearts [Abstract #189]. J Heart Lung Transplant. 15:1996;S86.
25. Ballantyne C, Masri B, Clubb F. Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation. Tex Heart Inst J. 23:1996;293-295.
26. Shackleton CR, Ettinger SL, McLoughlin MG, Scudamore CH, Miller RR, Keown PA. Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation. 49:1990;641-644.
27. Azuma H, Tilney N. Chronic graft rejection. Curr Opin Immunol. 6:1994;770-776.
28. Oubenaissa A, Mouas C, Bourgeois F, Moalic J, Menasché P. Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants. Circulation. 94:(Suppl 2):1996;254-259.
29. Kumasaka T, Quinlan W, Doyle N, Condon T, Bennett C, Doerschuk C. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 mAb and ICAM-1 mutant mice. J Clin Invest. 97:1996;2362-2369.